Advances in Penile and Testicular Cancer, An Issue of Urologic Clinics of North America

In this issue of <i>Urologic Clinics of North America</i>, guest editors Drs. Jeffrey M. Holzbeierlein and Philippe E. Spiess bring their considerable expertise to the topic of <b>Advances in Penile and Testicular Cancer</b>. Top experts in the field provide important clinical updates on the management of penile and scrotal cancer, discuss the current standards of care using evidence-based treatment guidelines, and provide insight on emerging discoveries. This issue provides critical information and updates needed to improve outcomes in patients with diseases that urologists do not see on a daily basis.<ul><li>Contains <b>12 relevant, practice-oriented topics,</b> including the psychosocial impact of penile cancer: an unmet need; what is on the horizon in clinical trials for penile and testicular cancer; the use of miRNA to predict teratoma and viable GCT after chemotherapy; testicular cancers survivorship and fertility preservation; and more.</li><li>Provides in-depth <b>clinical reviews on advances in penile and testicular cancer</b>, offering actionable insights for clinical practice.</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.</li></ul>